If you get this reference, you may need a statin.
October 30, 2026 at 2:18 PM
If you get this reference, you may need a statin.
( squints) Is one of them a statin?
November 4, 2026 at 8:31 AM
( squints) Is one of them a statin?
Was thinking that Chris Murphy was not remotely high on my list of Senators at risk for a stroke. Then I looked up his age. He's younger than I am. Guess I won't be skipping that statin.
November 2, 2026 at 8:51 PM
Was thinking that Chris Murphy was not remotely high on my list of Senators at risk for a stroke. Then I looked up his age. He's younger than I am. Guess I won't be skipping that statin.
I became a dietitian in 2 years.. have a Statin
November 3, 2026 at 11:56 PM
I became a dietitian in 2 years.. have a Statin
Is anything more 'middle-aged man' than getting a statin prescription? 😐
November 1, 2026 at 12:45 AM
Is anything more 'middle-aged man' than getting a statin prescription? 😐
Haven't had a chance to review our #Statin #Deprescribing Guideline and Algorithm yet?
Here's your friendly reminder ‼️
Find our new Statin resources in the link below👇 , including our guideline, algorithm, information pamphlet, plain language summary, & whiteboard video series:
buff.ly/m1lMxJh
Here's your friendly reminder ‼️
Find our new Statin resources in the link below👇 , including our guideline, algorithm, information pamphlet, plain language summary, & whiteboard video series:
buff.ly/m1lMxJh
November 3, 2026 at 5:05 PM
Haven't had a chance to review our #Statin #Deprescribing Guideline and Algorithm yet?
Here's your friendly reminder ‼️
Find our new Statin resources in the link below👇 , including our guideline, algorithm, information pamphlet, plain language summary, & whiteboard video series:
buff.ly/m1lMxJh
Here's your friendly reminder ‼️
Find our new Statin resources in the link below👇 , including our guideline, algorithm, information pamphlet, plain language summary, & whiteboard video series:
buff.ly/m1lMxJh
Circling back to the main point: I have no idea if my parents had high BP or high cholesterol and I have no way of finding out even though my cardiologist needs to know for purposes of statin-dosaging.
But that need is NOT WHY I HAVE THE RIGHT TO KNOW WHO MY PARENTS ARE.
But that need is NOT WHY I HAVE THE RIGHT TO KNOW WHO MY PARENTS ARE.
November 2, 2026 at 10:09 PM
Circling back to the main point: I have no idea if my parents had high BP or high cholesterol and I have no way of finding out even though my cardiologist needs to know for purposes of statin-dosaging.
But that need is NOT WHY I HAVE THE RIGHT TO KNOW WHO MY PARENTS ARE.
But that need is NOT WHY I HAVE THE RIGHT TO KNOW WHO MY PARENTS ARE.
A recent FDA enforcement report revealed a Class II recall of prescription atorvastatin calcium tablets—the generic version of Lipitor—due to the "Presence of Foreign Tablets/Capsules." The report does not specify what those foreign tablets or capsules are.
Cholesterol Pill Recall: Over 13,000 Bottles Recalled Over an Unusual Safety Concern
The affected tablets are known as a generic version of a popular statin.
www.yahoo.com
November 3, 2026 at 12:56 AM
A recent FDA enforcement report revealed a Class II recall of prescription atorvastatin calcium tablets—the generic version of Lipitor—due to the "Presence of Foreign Tablets/Capsules." The report does not specify what those foreign tablets or capsules are.
Published in The Lancet Healthy Longevity:
Efficacy and safety of #statin discontinuation in patients 65 years and older according to #frailty status: a population-wide retrospective cohort study in England using Clinical Practice Research Datalink data www.thelancet.com/journals/lan...
#OpenAccess
Efficacy and safety of #statin discontinuation in patients 65 years and older according to #frailty status: a population-wide retrospective cohort study in England using Clinical Practice Research Datalink data www.thelancet.com/journals/lan...
#OpenAccess
Efficacy and safety of statin discontinuation in patients 65 years and older according to frailty status: a population-wide retrospective cohort study in England using Clinical Practice Research Datal...
In older adults, statin discontinuation was associated with an increased risk of hospitalisation,
although this association diminished with increasing frailty. These findings could
inform individualis...
www.thelancet.com
November 3, 2026 at 4:05 PM
Published in The Lancet Healthy Longevity:
Efficacy and safety of #statin discontinuation in patients 65 years and older according to #frailty status: a population-wide retrospective cohort study in England using Clinical Practice Research Datalink data www.thelancet.com/journals/lan...
#OpenAccess
Efficacy and safety of #statin discontinuation in patients 65 years and older according to #frailty status: a population-wide retrospective cohort study in England using Clinical Practice Research Datalink data www.thelancet.com/journals/lan...
#OpenAccess
A massive new analysis from two of the world’s largest biomedical databases just linked statin use to roughly double the risk of dementia.
This is observational data, not a randomized trial, so it cannot prove causation.
www.frontiersin.org/journals/pha...
This is observational data, not a randomized trial, so it cannot prove causation.
www.frontiersin.org/journals/pha...
Frontiers | Association between statin therapy and dementia risk: evidence from All of Us and UK Biobank with coenzyme Q7-related mediation analysis
BackgroundStatins are widely prescribed for cardiovascular disease prevention in older adults; however, their association with dementia remains controversial...
www.frontiersin.org
November 1, 2026 at 6:23 PM
A massive new analysis from two of the world’s largest biomedical databases just linked statin use to roughly double the risk of dementia.
This is observational data, not a randomized trial, so it cannot prove causation.
www.frontiersin.org/journals/pha...
This is observational data, not a randomized trial, so it cannot prove causation.
www.frontiersin.org/journals/pha...
Statin Literature Update, Weeks 41 and 42 (2026)
· Statins An Unexpected Eradication Boost for H. pylori?
· Liver disease? Don’t skip the statin
· Statins Worth It? Most Patients Say No
mailchi.mp/aaf192055453...
· Statins An Unexpected Eradication Boost for H. pylori?
· Liver disease? Don’t skip the statin
· Statins Worth It? Most Patients Say No
mailchi.mp/aaf192055453...
November 2, 2026 at 5:05 PM
Statin Literature Update, Weeks 41 and 42 (2026)
· Statins An Unexpected Eradication Boost for H. pylori?
· Liver disease? Don’t skip the statin
· Statins Worth It? Most Patients Say No
mailchi.mp/aaf192055453...
· Statins An Unexpected Eradication Boost for H. pylori?
· Liver disease? Don’t skip the statin
· Statins Worth It? Most Patients Say No
mailchi.mp/aaf192055453...
CoQ10 tissue levels decline 30% naturally by age 40, with statin use causing additional depletion to just 55% of peak capacity.
https://news.gmj.ge/briefs/the-silent-energy-crisis-how-coq10-levels-plummet-with-age-and-statin-use/
https://news.gmj.ge/briefs/the-silent-energy-crisis-how-coq10-levels-plummet-with-age-and-statin-use/
The Silent Energy Crisis: How CoQ10 Levels Plummet With Age and Statin Use
CoQ10 tissue levels decline 30% naturally by age 40, with statin use causing additional depletion to just 55% of peak capacity.
news.gmj.ge
November 2, 2026 at 7:27 AM
CoQ10 tissue levels decline 30% naturally by age 40, with statin use causing additional depletion to just 55% of peak capacity.
https://news.gmj.ge/briefs/the-silent-energy-crisis-how-coq10-levels-plummet-with-age-and-statin-use/
https://news.gmj.ge/briefs/the-silent-energy-crisis-how-coq10-levels-plummet-with-age-and-statin-use/
NY is a hilarious argument In support of patronage.
Our elections are SOOOO fast. Turns out overstaffing the heck out of them is, in fact, effective.
I wish we had a similar approach to primary care medicine. Flood the zone with paras for blood sugar & pressure checks, statin distribution.
Our elections are SOOOO fast. Turns out overstaffing the heck out of them is, in fact, effective.
I wish we had a similar approach to primary care medicine. Flood the zone with paras for blood sugar & pressure checks, statin distribution.
November 3, 2026 at 3:23 PM
NY is a hilarious argument In support of patronage.
Our elections are SOOOO fast. Turns out overstaffing the heck out of them is, in fact, effective.
I wish we had a similar approach to primary care medicine. Flood the zone with paras for blood sugar & pressure checks, statin distribution.
Our elections are SOOOO fast. Turns out overstaffing the heck out of them is, in fact, effective.
I wish we had a similar approach to primary care medicine. Flood the zone with paras for blood sugar & pressure checks, statin distribution.
But on the health side and life side of things, it's not been that great. Although I'm hoping it will start looking up as we're slowly getting answers. I still have some testing coming up but we think that the neurological issues that have been getting worse are due to extended statin use.
November 2, 2026 at 1:40 PM
But on the health side and life side of things, it's not been that great. Although I'm hoping it will start looking up as we're slowly getting answers. I still have some testing coming up but we think that the neurological issues that have been getting worse are due to extended statin use.
Intensive vs More Intensive Lipid-Lowering Therapy in Statin-Naive Patients jamanetwork.com/journals/jam...
Can coronary atherosclerosis actually regress?
FLOWPROMOTE trial analysis, published in JAMA Cardiology, shows remarkable coronary plaque regression with intensive LDL-C lowering.
Can coronary atherosclerosis actually regress?
FLOWPROMOTE trial analysis, published in JAMA Cardiology, shows remarkable coronary plaque regression with intensive LDL-C lowering.
Intensive vs More Intensive Lipid-Lowering Therapy in Statin-Naive Patients
This secondary analysis of the FLOWPROMOTE randomized clinical trial investigates if more intensive lipid-lowering therapy leads to greater regression of coronary atherosclerotic plaque across the ent...
jamanetwork.com
November 2, 2026 at 4:00 AM
Intensive vs More Intensive Lipid-Lowering Therapy in Statin-Naive Patients jamanetwork.com/journals/jam...
Can coronary atherosclerosis actually regress?
FLOWPROMOTE trial analysis, published in JAMA Cardiology, shows remarkable coronary plaque regression with intensive LDL-C lowering.
Can coronary atherosclerosis actually regress?
FLOWPROMOTE trial analysis, published in JAMA Cardiology, shows remarkable coronary plaque regression with intensive LDL-C lowering.
Thank you! Just realized I need to my profile statin Blue in a red state (TX) BRB 💙💙
November 4, 2026 at 7:23 PM
Thank you! Just realized I need to my profile statin Blue in a red state (TX) BRB 💙💙
More intensive vs intensive statin therapy in statin-naive stable CAD (FLOWPROMOTE secondary analysis, n=104, 18 mo)
Rosuvastatin 40 + ezetimibe vs atorvastatin 40:
LDL-C: 42.5 vs 69.5 mg/dL
Total plaque volume: −69.8 vs −39.0 mm³ (difference −30.9 mm³, P=.02)
JAMA Cardiol
Rosuvastatin 40 + ezetimibe vs atorvastatin 40:
LDL-C: 42.5 vs 69.5 mg/dL
Total plaque volume: −69.8 vs −39.0 mm³ (difference −30.9 mm³, P=.02)
JAMA Cardiol
Intensive vs More Intensive Lipid-Lowering Therapy and Plaque… · CurrentCardio
Randomized controlled trial · 104 patients · JAMA Cardiol, 2026. This secondary analysis of the FLOWPROMOTE randomized clinical trial demonstrated that in statin-naive patients with CAD, more intensiv...
currentcardio.com
October 31, 2026 at 8:42 AM
More intensive vs intensive statin therapy in statin-naive stable CAD (FLOWPROMOTE secondary analysis, n=104, 18 mo)
Rosuvastatin 40 + ezetimibe vs atorvastatin 40:
LDL-C: 42.5 vs 69.5 mg/dL
Total plaque volume: −69.8 vs −39.0 mm³ (difference −30.9 mm³, P=.02)
JAMA Cardiol
Rosuvastatin 40 + ezetimibe vs atorvastatin 40:
LDL-C: 42.5 vs 69.5 mg/dL
Total plaque volume: −69.8 vs −39.0 mm³ (difference −30.9 mm³, P=.02)
JAMA Cardiol
Naja, das LDL-Cholesterin war bei 160, aber ansonsten habe ich keinerlei kardiovaskuläre Risikofaktoren. Also weiterhin kein Statin. 10 kg abnehmen, hat er gesagt, würde mir nicht schaden. Mein innerer Schweinehund hat laut gebellt.
October 30, 2026 at 11:42 AM
Naja, das LDL-Cholesterin war bei 160, aber ansonsten habe ich keinerlei kardiovaskuläre Risikofaktoren. Also weiterhin kein Statin. 10 kg abnehmen, hat er gesagt, würde mir nicht schaden. Mein innerer Schweinehund hat laut gebellt.
I’m sure there’s a name for this type of “grilled cheese”: I fried the bread while I fried the cheese in the same pan, then closed it together, soft side out, and made a warm cheesy crunchy sandwich. One wonders why I’m on a statin, weird. Anyway sum1 know if that typa sammich has a fancy name?
November 1, 2026 at 3:44 AM
I’m sure there’s a name for this type of “grilled cheese”: I fried the bread while I fried the cheese in the same pan, then closed it together, soft side out, and made a warm cheesy crunchy sandwich. One wonders why I’m on a statin, weird. Anyway sum1 know if that typa sammich has a fancy name?
PCSK9 inhibitors work really well.
( There is 2 shots ( 2 week ) 1 pill, 1 6month shot that is rnai interference.
Unlike statins they lower heart attack incidence.
You can mitigate some ( but not all ) of statin damage with coq10 use. ( But it's also expensive.
( There is 2 shots ( 2 week ) 1 pill, 1 6month shot that is rnai interference.
Unlike statins they lower heart attack incidence.
You can mitigate some ( but not all ) of statin damage with coq10 use. ( But it's also expensive.
November 4, 2026 at 10:31 AM
PCSK9 inhibitors work really well.
( There is 2 shots ( 2 week ) 1 pill, 1 6month shot that is rnai interference.
Unlike statins they lower heart attack incidence.
You can mitigate some ( but not all ) of statin damage with coq10 use. ( But it's also expensive.
( There is 2 shots ( 2 week ) 1 pill, 1 6month shot that is rnai interference.
Unlike statins they lower heart attack incidence.
You can mitigate some ( but not all ) of statin damage with coq10 use. ( But it's also expensive.
I haven't really tried to rx enlicitide yet. How is coverage, particularly compared to injectable PCSK9i?
(I know you had rhabdo to statin, IME that still requires a peer-to-peer: like WTF?)
(I know you had rhabdo to statin, IME that still requires a peer-to-peer: like WTF?)
November 1, 2026 at 6:08 PM
I haven't really tried to rx enlicitide yet. How is coverage, particularly compared to injectable PCSK9i?
(I know you had rhabdo to statin, IME that still requires a peer-to-peer: like WTF?)
(I know you had rhabdo to statin, IME that still requires a peer-to-peer: like WTF?)